This article is the first of four to explore the effects of age-related changes in impairment evaluations as defined by the fifth and sixth editions of the AMA Guides to the Evaluation of Permanent Impairment (AMA Guides). With respect to the cardiovascular system, impairment ratings for the following conditions commonly are affected by the aging process: coronary artery disease, valvular heart disease, arrhythmias/dysrhythmias, hypertension, and peripheral vascular disease. Impairment ratings in the fifth and sixth editions of the AMA Guides for the pulmonary system apply corrections for age with respect to certain measurements such as forced vital capacity. The normal aging process does not significantly affect impairment ratings for either hematological impairments or the endocrine system, nor does normal aging significantly affect the impairment ratings for mammary glands. With careful attention to the diagnosis and causative factors, evaluators may find that the normal aging process can affect impairment ratings associated with metabolic bone disease. Evaluating physician typically must determine impairment secondary to a specific cause (eg, injury or exposure) and therefore must consider if other factors are contributing to the impairment.
Cocchiarella L, Andersson GBJ, eds. AMA Guides to the Evaluation of Permanent Impairment, 5th ed. Chicagol: AMA Press; 2001.
Rondinelli R, ed. AMA Guides to the Evaluation of Permanent Impairment, 6th ed. Chicago: AMA Press; 2008.
Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: mobility, mortality, and costs. Clin Geriatr Med. 2009; 25(4):563–577. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797320/)
Gillespie CD, Hurvitz KS. Prevalence of hypertension and controlled hypertension–United States, 2007–2010. (https://www.cdc.gov/MMWr/preview/mmwrhtml/su6203a24.htm)
Ong KL, Cheung BM, Man YB, et al.Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007; 49(1):69–75. (https://www.ncbi.nlm.nih.gov/pubmed/17159087)
Mohty D, Pislaru S. Valvular heart disease in elderly adults. Up-to-date; literature current through July 2018. (https://www.uptodate.com/contents/valvular-heart-disease-in-elderly-adults)
Go AS, Hylek EM, Phillips KA, et al.Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management in stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA. 2001; 285:2370–2375. (https://www.ncbi.nlm.nih.gov/pubmed/11343485)
Selvin E, Erlinger TP. Prevalence and risk factors for peripheral arterial disease in the United States. Results from The National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004; 110:738–743. (https://www.ncbi.nlm.nih.gov/pubmed/15262830)
Taffet GE. Normal aging. Up-to-date; literature current through July 2018. (https://www.uptodate.com/contents/normal-aging)
Morley JE. Overview of endocrine disorders. (https://www.merckmanuals.com/professional/endocrineand-metabolic-disorders/principles-of-endocrinology/overview-of-endocrine-disorders)
Aging changes in hormone production. (https://medlineplus.gov/ency/article/004000.htm)
Ferrari E, Cravello L, Muzzoni B, et al.Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Europ J Endocrin. 2001; 144:319–329. (https://www.ncbi.nlm.nih.gov/pubmed/11275940)
Puzianowska-Kuznicka M. Changes of the hypothalamic pituitary thyroid axis in aging. Thyroid Research. 2013; 6(Suppl 2):A49. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618197/)
Gesing A. The thyroid gland in the process of aging. Thyroid Research. 2015; 8(Suppl 1):A8. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480281/)
Need AG, O'Loughlin PD, Morris HA, et al.The effects of age and other variables and serum parathyroid hormone in postmenopausal women attending and osteoporosis center. J Clin Endo Met. 2004;89(4):1646–1649. (https://www.ncbi.nlm.nih.gov/pubmed/15070925)
Harris MI, Flegal KM, Eberhardt MS, et al.Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1980–1994. Diabetes Care. 1998; 21(4):518–24. (https://www.ncbi.nlm.nih.gov/pubmed/9571335)
Cowie CC, Rust KF, Byrd-Holt DD, et al.Prevalence of diabetes and impaired fasting glucose in the U.S. population: National Health and Nutrition Examination Survey, 1999–2002. Diabetes Care. 2006; 21(4):518–24. (https://www.ncbi.nlm.nih.gov/pubmed/16732006)
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 2312 | 2312 | 92 |
Full Text Views | 25 | 25 | 0 |
PDF Downloads | 0 | 0 | 0 |